The disinfection technology we need right now and tomorrow

Christie CounterAct™ commercial UVC disinfection fixtures contain patented Care222® technology that emits filtered far-UVC 222nm light while meeting established safety guidelines, designed to neutralize pathogens with people present. Care222 is also the world’s first UVC technology with a proprietary optical filter that blocks potentially harmful longer UVC wavelengths from being emitted.

An added layer of defense

The far-UVC 222nm light that Care222 technology emits provides an added layer of defense against pathogens like the SARS-CoV-2 coronavirus that causes COVID-19. CounterAct CA-20 fixtures are designed for high-ceiling applications, from corporate, government, and education, to transit hubs, cinemas, museums, theme parks and indoor locations, and beyond.

Purpose-built with your needs in mind

Configurable, automated operation within the current limits of ACGIH and IEC occupational and environmental health guidelines, which can be reconfigured if these guidelines evolve over time.

Programmable to operate on a specific schedule according to your use case

As easy to install as traditional commercial lighting fixtures, with automated control via an app

Easy-to-service for straightforward lamp changes

Instant on/off at full output power, and frequent on/off cycles don’t affect lamp life

Available in black or white to fit existing color schemes

Designed for high-ceiling applications

Flexible leasing options are available

Design services

We can work with you to determine how many CounterAct fixtures you need to provide effective coverage of your indoor space. We offer consulting and installation services through our Professional Services group to help with a deployment strategy to add a layer of defense against pathogens in shared indoor spaces.